Acid phosphatase biosensing via Prussian Blue-Functionalized heterometallic covalent organic framework nanozymes
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2025
DOI: 10.1016/j.saa.2025.126497 ↗Kurz gefasst
Fachartikel in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2025. Verfasst von Yaxin Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jiangxi Medical College, Nanchang University, Key Laboratory of New Drug Transformation and Evaluation of Jiangxi Province, Nanch…. Hauptthemen laut MEDLINE: Ferrocyanides, Metal-Organic Frameworks, Biosensing Techniques, Acid Phosphatase. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Jiangxi Provincial Natural Science Foundation, TCM Science and Technology Project of Jiangxi Province.
Abstract (Originalsprache)
The assessment of acid phosphatase (ACP) levels is of significant importance for evaluating a variety of physiological and pathological conditions, monitoring disease progression and guiding clinical therapy. We engineered a platform for ACP sensitive detection utilizing Prussian blue (PB)-incorporated heterometallic covalent organic framework (COF) nanozyme. The synthesized COF@PB/AuPt NPs demonstrate a synergistic enhancement in peroxidase-like catalytic activity originating from the combined action of PB and AuPt NPs. The introduction of COF as a support matrix endows the nanozyme with remarkable dispersity and stability, maintaining functionality even after prolonged storage for six months. The COF@PB/AuPt nanozyme can facilitate the oxidation of 3,3',5,5'-tetramethylbenzidine (TMB) to oxidized TMB (oxTMB) under H2O2-rich conditions, which can be inhibited by reductive ascorbic acid (AA). Concurrently, ACP catalyzes the hydrolysis of L-ascorbic acid-2-phosphate into AA, which can effectively inhibit the oxidation reaction of TMB. The sensitive assay for ACP has been successfully executed, achieving a remarkably low detection limit of 2.2 mU/L. The platform demonstrates exceptional selectivity against enzymatic interferents and robust analytical performance in complex biological matrices, as evidenced by recoveries of 95-107 % and RSD below 5 % in fetal bovine serum, underscoring its potential for clinical diagnostics and biomedical research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Jiangxi Medical College, Nanchang University, Key Laboratory of New Drug Transformation and Evaluation of Jiangxi Province, Nanchang 330031, PR China.
- School of Pharmacy, Jiangxi Medical College, Nanchang University, Key Laboratory of New Drug Transformation and Evaluation of Jiangxi Province, Nanchang 330031, PR China. Electronic address: zhaotiansheng@ncu.edu.cn.
- School of Pharmacy, Jiangxi Medical College, Nanchang University, Key Laboratory of New Drug Transformation and Evaluation of Jiangxi Province, Nanchang 330031, PR China. Electronic address: lin@ncu.edu.cn.
Förderung
- Jiangxi Provincial Natural Science Foundation
- TCM Science and Technology Project of Jiangxi Province
Zitieren
APA
Wang, Y., Zhong, Z., Ya, J., Li, X., Yan, Y., Zhao, T., & Li, N. (2025). Acid phosphatase biosensing via Prussian Blue-Functionalized heterometallic covalent organic framework nanozymes. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. https://doi.org/10.1016/j.saa.2025.126497
Vancouver
Wang Y, Zhong Z, Ya J, Li X, Yan Y, Zhao T, et al. Acid phosphatase biosensing via Prussian Blue-Functionalized heterometallic covalent organic framework nanozymes. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2025. doi:10.1016/j.saa.2025.126497
BibTeX
@article{Wang2025,
author = {Wang, Yaxin and Zhong, Zhiying and Ya, Jinpan and Li, Xinyuan and Yan, Yan and Zhao, Tiansheng and Li, Na},
title = {Acid phosphatase biosensing via Prussian Blue-Functionalized heterometallic covalent organic framework nanozymes},
journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
year = {2025},
doi = {10.1016/j.saa.2025.126497}
}
EUVIMED